The global nuclear medicine radioisotopes market is expected to achieve a strong compound annual growth rate (CAGR) of 8% over the next decade. This growth trajectory is projected to elevate the market size from $8.82 billion in 2023 to $19.04 billion by the end of 2033. Nuclear medicine radioisotopes play a crucial role in modern healthcare by offering diagnostic and therapeutic...